NCT05543330 2025-07-20A Phase Ib/II Clinical Trial of M701 in the Treatment of Malignant Pleural Effusions Caused by NSCLCWuhan YZY Biopharma Co., Ltd.Phase 1/2 Recruiting96 enrolled